Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders

Journal of Ocular Pharmacology and Therapeutics(2023)10.1089/jop.2022.0174Source: DataRank Database

Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders is a research paper published in Journal of Ocular Pharmacology and Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 54 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access54 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 8.23)OA: greenTopics (31)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Steven E. Wilson ORCID

Live enrichment

PubMed:36877777 PMC:PMC10079252 OpenAlex:https://openalex.org/W4323307261

NEI NIH HHS

Grant: P30 EY025585

FWCI

8.23

Citation Percentile

1.0%

Influential Citations

Citation Trend

2022

2023

2024

2025

2026

greenLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10079252/pdf/jop.2022.0174.pdf

GREENhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10079252/pdf/jop.2022.0174.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10079252/pdf/jop.2022.0174.pdf

publisherhttps://journals.sagepub.com/doi/full-xml/10.1089/jop.2022.0174

publisherhttps://journals.sagepub.com/doi/pdf/10.1089/jop.2022.0174

Fields of Study

Corneal Surgery and TreatmentsOcular Surface and Contact LensDermatologic Treatments and ResearchMedicine

MeSH Terms

Angiotensin-Converting Enzyme InhibitorsAnimalsCicatrixCorneal Dystrophies, HereditaryEye DiseasesFibrosisHumansRabbitsTransforming Growth Factor betaLosartanAngiotensin Receptor AntagonistsCorneal Injuries

Keywords

MedicineLosartanFibrosisCorneal dystrophyGlaucomaCorneaOphthalmologyInternal medicineAngiotensin IIReceptorBullous PemphigoidTgf BetaPersistent Epithelial DefectCorneal FibrosisGlaucoma Bleb Fibrosis

Sustainable Development Goals

SDG 0: Good health and well-being